A photo of Joel Sorger.

Co-Director, Sarcoma Program

Director, Pediatric Joint Replacement Surgery

Associate Professor, UC Department of Pediatrics

513-636-4787

513-636-3928

Board Certified

"I want families to know that I am always available to them. I make myself accessible to answer their questions or talk about whatever is on their mind."

My Biography & Research

Biography

My dad inspired me to become a doctor. And now, when I work with children and families, I treat them like they are part of my own family.

As a pediatric orthopedist, I specialize in caring for children with cancer and in providing joint replacement surgery.

I want families to know that I am always available to them. I make myself accessible to answer their questions or talk about whatever is on their mind.

My research focuses on cancer survival in children.

When I’m not at work I enjoy playing golf and spending time with my family.

Clinical Interests

Orthopaedic oncology (sarcoma surgery) and joint replacement surgery

Academic Affiliation

Associate Professor, UC Department of Pediatrics

Clinical Divisions

Orthopaedic Surgery, Hemangioma and Vascular Malformations, Sarcoma, Hip Preservation

Research Divisions

Orthopaedics



Blog Posts

COVID-19 School Study in JAMA Tops Most-Shared Findings From July 2020

Infectious Diseases and Vaccines

COVID-19 School Study in JAMA Tops Most-Shared Findings From July 2020

Joel I. Sorger, MD, Katherine A. Auger, MD, MSc ...8/11/2020

My Locations

My Education

BS: Biology, University of Richmond, VA, August 1983-May 1987.

MD: Medical College of Virginia, Richmond, VA, August 1987-May 1991.

Intern: General Surgery Intern, University of Cincinnati, Cincinnati, OH, July 1991-June 1992.

Residency: General surgery resident, University of Cincinnati College of Medicine, 1992-1993; Orthopaedic surgery resident, University of Cincinnati College of Medicine, 1994-1998.

Fellowship: Orthopaedic research fellow, Noyes-Giannestras Biomechanics Lab, University of Cincinnati Department of Aerospace Engineering, 1993-1994; Bone and Soft Tissue Sarcoma Management Fellowship (Orthopaedic Oncology), Harvard University, Massachusetts General Hospital and Boston, Children’s Hospital, August 1998-July 1999.

Certification: American Board of Orthopaedic Surgeons.

My Publications

Implant Survival and Clinical Outcomes of Total Hip Arthroplasty in Adolescent and Young Adult Patients. Zeitlinger, L; Gemayel, A; Whitlock, P; Sorger, J. 2021; 05:062-069.

A large intermuscular shoulder lipoma causing pain and weakness in an 87-year-old patient: a case report. Hasan, SS; O'Loughlin, JP; Sorger, JI. JSES International. 2021; 5:154-157.

Solitary myofibroma preceding the development of multicentric myofibromatosis: A report of two cases with surveillance recommendations. Todd, K; Kim, HK; Szabo, S; Johnson, S; Pressey, J; Nagarajan, R; Sorger, J; Dasgupta, R; Turpin, B. Pediatric Blood and Cancer. 2020; 67.

Orthopedic issues in vascular anomalies. Spencer, SA; Sorger, JI. Seminars in Pediatric Surgery. 2020; 29.

Pathological response in children and adults with large unresected intermediate-grade or high-grade soft tissue sarcoma receiving preoperative chemoradiotherapy with or without pazopanib (ARST1321): a multicentre, randomised, open-label, phase 2 trial. Weiss, AR; Chen, Y; Scharschmidt, TJ; Chi, Y; Tian, J; Black, JO; Davis, JL; Fanburg-Smith, JC; Zambrano, E; Anderson, J; et al. The Lancet Oncology. 2020; 21:1110-1122.

A phase II study of larotrectinib for children with newly diagnosed solid tumors and relapsed acute leukemias harboring TRK fusions: Children’s Oncology Group study ADVL1823. Laetsch, TW; Ludwig, K; Barkauskas, DA; DuBois, SG; Ronan, J; Rudzinski, ER; Memken, A; Sorger, J; Reid, JM; Bhatla, T; et al. Journal of Clinical Oncology. 2020; 38:tps10560-tps10560.

Preoperative chemoradiation +/- pazopanib in non-rhabdomyosarcoma soft tissue sarcoma (NRSTS): A report from Children's Oncology Group (COG) and NRG Oncology. Weiss, AR; Chi, Y; Chen, Y; Choy, E; Davis, JL; Fanburg-Smith, J; Hawkins, DS; Kayton, M; Million, L; Okuno, SH; et al. Journal of Clinical Oncology. 2019; 37:11002-11002.

ARST1321: Pazopanib neoadjuvant trial in non-rhabdomysarcoma soft tissue sarcomas: A report of major wound complications. Scharschmidt, T; Chen, Y; Wang, D; Chi, Y; Kayton, M; Sorger, J; Randall, RL; Hawkins, DS; Weiss, AR. Journal of Clinical Oncology. 2019; 37:11059-11059.

Bone Tumors and Reconstructive Options in Pediatric and Young Adult Patients. Sorger, JI; Scharschmidt, T; Rajani, R; Randall, RL. Instructional course lectures. 2019; 68:613-626.

Pazopanib therapy for desmoid tumors in adolescent and young adult patients. Agresta, L; Kim, H; Turpin, BK; Nagarajan, R; Plemmons, A; Szabo, S; Dasgupta, R; Sorger, JI; Pressey, JG. Pediatric Blood and Cancer. 2018; 65.